Evidence map›Paper›PMID 30581096›Full record

ArticleiScience2019

Hypoxic and Cold Adaptation Insights from the Himalayan Marmot Genome.

Liang Bai, Baoning Liu, Changmian Ji, Sihai Zhao, Siyu Liu, Rong Wang, Weirong Wang, Pu Yao, Xuming Li, Xiaojun Fu and 15 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in iScience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. One health (Amsterdam, Netherlands) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Hibernation and hemostasis.Frontiers in physiology · 2023
    Review
  14. Comparative genomic analysis ofFrontiers in molecular biosciences · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A pan-metazoan concept for adult stem cells: the wobbling Penrose landscape.Biological reviews of the Cambridge Philosophical Society · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 3 countries.

Liang BaiLaboratory Animal Center, Xi'an Jiaotong University Health Science Center, No.76, Yanta West Road, Xi'an, Shaanxi 710061, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China.
Baoning LiuLaboratory Animal Center, Xi'an Jiaotong University Health Science Center, No.76, Yanta West Road, Xi'an, Shaanxi 710061, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China.
Changmian JiBiomarker Technologies Corporation, Beijing 101200, China.
Sihai ZhaoLaboratory Animal Center, Xi'an Jiaotong University Health Science Center, No.76, Yanta West Road, Xi'an, Shaanxi 710061, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China.
Siyu LiuDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
Rong WangLaboratory Animal Center, Xi'an Jiaotong University Health Science Center, No.76, Yanta West Road, Xi'an, Shaanxi 710061, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China.
Weirong WangLaboratory Animal Center, Xi'an Jiaotong University Health Science Center, No.76, Yanta West Road, Xi'an, Shaanxi 710061, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China.
Pu YaoBiomarker Technologies Corporation, Beijing 101200, China.
Xuming LiBiomarker Technologies Corporation, Beijing 101200, China.
Xiaojun FuBiomarker Technologies Corporation, Beijing 101200, China.
Haiyan YuBiomarker Technologies Corporation, Beijing 101200, China.
Min LiuBiomarker Technologies Corporation, Beijing 101200, China.
Fengming HanBiomarker Technologies Corporation, Beijing 101200, China.
Ning GuanBiomarker Technologies Corporation, Beijing 101200, China.
Hui LiuBiomarker Technologies Corporation, Beijing 101200, China.
Dongyuan LiuBiomarker Technologies Corporation, Beijing 101200, China.
Yuanqing TaoQinghai Institute for Endemic Disease Prevention and Control, Xining, Qinghai 811602, China.
Zhongdong WangQinghai Institute for Endemic Disease Prevention and Control, Xining, Qinghai 811602, China.
Shunsheng YanCenters for Disease Control and Prevention, Urumqi, Xinjiang 830054, China.
Greg FlorantDepartment of Biology, Colorado State University, Ft. Collins, CO 80523, USA.
Michael T ButcherDepartment of Biological Sciences, Youngstown State University, Youngstown, OH 44555, USA.
Jifeng ZhangCenter for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.
Hongkun ZhengBiomarker Technologies Corporation, Beijing 101200, China. Electronic address: zhenghk@biomarker.com.cn.
Jianglin FanDepartment of Molecular Pathology, Faculty of Medicine, Interdisciplinary Graduate School of Medicine, University of Yamanashi, 1110, Shimokato, Chuo, Yamanashi 409-3898, Japan. Electronic address: jianglin@yamanashi.ac.jp.
Enqi LiuLaboratory Animal Center, Xi'an Jiaotong University Health Science Center, No.76, Yanta West Road, Xi'an, Shaanxi 710061, China; Research Institute of Atherosclerotic Disease, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an, Shaanxi 710061, China. Electronic address: liuenqi@mail.xjtu.edu.cn.
Biomarker Technologies (China) · CNXi'an Jiaotong University · CNQinghai Institute for Endemic Diease Prevention and Control · CNUniversity of Michigan–Ann Arbor · USColorado State University · USUniversity of Yamanashi · JPXinjiang Uygur Autonomous Region Disease Prevention and Control Center · CNYoungstown State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Himalayan marmot (Marmota himalayana) is a hibernating mammal that inhabits the high-elevation regions of the Himalayan mountains. Here we present a draft genome of the Himalayan marmot, with a total assembly length of 2.47 Gb. Phylogenetic analyses showed that the Himalayan marmot diverged from the Mongolian marmot approximately 1.98 million years ago. Transcriptional changes during hibernation included genes responsible for fatty acid metabolism in liver and genes involved in complement and coagulation cascades and stem cell pluripotency pathways in brain. Two selective sweep genes, Slc25a14 and ψAamp, showed apparent genotyping differences between low- and high-altitude populations. As a processed pseudogene, ψAamp may be biologically active to influence the stability of Aamp through competitive microRNA binding. These findings shed light on the molecular and genetic basis underlying adaptation to extreme environments in the Himalayan marmot.

Indexed as

BioinformaticsEvolutionary BiologyGeneticsOmicsPhysiology

Identifiers

PMID30581096
PMCPMC6354217
OpenAlexW2905683534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.